Naftidrofuryl in the treatment of vascular dementia

European Archives of Psychiatry and Clinical Neuroscience

Volumn 251, Issue 6, 2001, Pages 247-254

  Moller H J ^a   Hartmann, A ^b   Kessler, C ^c   Rainer, M ^d   Brown, T ^e   Gamand, S ^e   Lehert, P ^f  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d DANUBE HOSPITAL   (Austria)

^e Monterre LIPHA SA   (France)

^f UNIVERSITY OF MONS   (Belgium)

Author keywords

Cerebrovascular disease; Dementia, vascular; Naftidrofuryl; Randomised controlled trials

Indexed keywords

NAFTIDROFURYL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIINFARCT DEMENTIA; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT;

EID: 0035709477     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007541     Document Type: Article

References (32)

1. Protocol to demonstrate slowing of Alzheimer's disease progression. Position paper from the International Working Group on Harmonisation of Dementia Drug Guidelines
2. Etude double-aveugle de l'efficacité du naftidrofuryl dans les troubles cognitifs liés à la senescence
3. Criteria for the diagnosis of ischaemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
4. Efficacy of naftidrofuryl in patients with vascular or mixed dementia: Results of a multicenter double-blind trial
5. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician
6. Prevention of dementia in randomised double-blind placebo controlled Systolic Hypertension in Europe (Syst-Eur) trial
7. Risk factors for dementia associated with multiple cerebral infarcts: A case control analysis in predominantly African American hospital based patients
8. Naftidrofuryl in the treatment of mild senile dementia. A double-blind study
9. Cerebral blood flow in dementia
10. Epidemiology of vascular dementia
11. Action combinée du Praxilène et d'exercices d'entraînement mental sur les troubles de la mémoire de sujets âgés
12. Platelet aggregation after naftidrofuryl application in vitro and ex vivo
13. Postischaemic breakdown in hippocampal protein synthesis and amnesic deficits in rats: Pharmacological improvement by curative naftidrofuryl treatment
14. Alzheimer's Disease Assessment Scale (ADAS)
15. Challenges in vascular dementia research
16. A new depression scale designed to be sensitive to change
17. Clinical global impressions
18. Vascular dementia: A contemporary review of epidemiology, diagnosis, prevention and treatment
19. Naftidrofuryl inhibits contractions to serotonin in intact and de-endothelialized cerebral arteries in vitro
20. Letter
21. Vascular dementia: Diagnostic criteria for research studies
22. A new rating scale for Alzheimer's disease
23. Efficacy of naftidrofuryl in patients with moderate senile dementia
24. A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment - Geriatric (SCAG)
25. Naftidrofuryl oxalate improves impaired brain glucose metabolism after induced cerebral metabolism in rats
26. Prevalence and etiology of dementia in a Japanese community
27. The clinical diagnosis of Alzheimer's disease
28. Clinical trial designs for demonstrating disease course altering effects in dementia
29. Letter